Catalyst Wire Dossier Catalyst Wire Dossier

Riprazo HCT

· Novartis Europharm Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Riprazo HCT, covering 2012-09-20 to 2012-09-20. Get the full timeline:

Most recent: EMA Withdrawn: Riprazo HCT (aliskiren;hydrochlorothiazide) — Novartis Europharm Ltd.

See pricing